Wang Zhen, Su Fuhong, Rogiers Peter, Vincent Jean-Louis
Department of Intensive Care, Erasme Hospital, Free University of Brussels, Belgium.
Crit Care Med. 2007 Nov;35(11):2594-600. doi: 10.1097/01.CCM.0000287590.55294.40.
To investigate the effects of activated protein C (APC) in a clinically relevant animal model of septic shock.
Prospective, randomized, controlled study.
University medical center research laboratory.
Eighteen female sheep (body weight, 27-35 kg).
Animals were fasted, anesthetized, invasively monitored, and mechanically ventilated before receiving 0.5 g/kg body weight of feces intraperitoneally to induce sepsis. Fluid resuscitation with Ringer lactate was titrated to maintain pulmonary artery occlusion pressure at baseline levels. No vasoactive agents or antibiotics were used. Two hours after the induction of sepsis, animals were randomized to receive an infusion of APC (24 microg x kg(-1) x hr(-1), n = 9) or an equivalent volume of vehicle (n = 9) throughout the experimental period.
The APC-treated animals had significantly higher arterial pressure, urine output, PaO2/FIO2 ratios, and thoracopulmonary compliance than the control animals. They had lower pulmonary arterial pressure and arterial lactate concentrations than the control animals. Plasma colloid oncotic pressure was better maintained in the APC-treated group than in the control group (p < .05). Prothrombin time and activated partial thromboplastin time were altered less, and plasma D-dimer concentrations were significantly lower in the APC-treated group than in the control group (p < .05). The blood protein C concentration and platelet count were maintained better in the APC-treated group than in the control group (p < .05). APC administration was associated with significantly longer survival (median, 27 hrs vs. 20 hrs; p < .05). At postmortem examination, the lung wet/dry ratio was significantly lower in the APC group than in the control group (6.3 +/- 0.7 vs. 7.1 +/- 1.2, p < .05).
In this clinically relevant model of septic shock due to fecal peritonitis, administration of APC had beneficial effects on hemodynamic variables, gas exchange, lactic acidosis, and coagulation abnormalities. Higher colloid oncotic pressures and lower lung wet/dry ratios at autopsy suggest preserved endothelial integrity. APC administration resulted in prolonged survival.
在脓毒性休克的临床相关动物模型中研究活化蛋白C(APC)的作用。
前瞻性、随机、对照研究。
大学医学中心研究实验室。
18只雌性绵羊(体重27 - 35千克)。
动物禁食、麻醉、进行有创监测并机械通气,然后腹腔内注射0.5克/千克体重的粪便以诱导脓毒症。用乳酸林格液进行液体复苏,滴定以维持肺动脉闭塞压在基线水平。未使用血管活性药物或抗生素。脓毒症诱导2小时后,动物被随机分组,在整个实验期间接受APC输注(24微克×千克⁻¹×小时⁻¹,n = 9)或等量的赋形剂(n = 9)。
接受APC治疗的动物的动脉压、尿量、PaO₂/FIO₂比值和胸肺顺应性显著高于对照组动物。它们的肺动脉压和动脉血乳酸浓度低于对照组动物。APC治疗组的血浆胶体渗透压比对照组维持得更好(p < 0.05)。APC治疗组的凝血酶原时间和活化部分凝血活酶时间改变较小,血浆D - 二聚体浓度显著低于对照组(p < 0.05)。APC治疗组的血液蛋白C浓度和血小板计数比对照组维持得更好(p < 0.05)。给予APC与显著更长的生存期相关(中位数,27小时对20小时;p < 0.05)。尸检时,APC组的肺湿/干比显著低于对照组(6.3 ± 0.7对7.1 ± 1.2,p < 0.05)。
在这种因粪性腹膜炎导致的脓毒性休克的临床相关模型中,给予APC对血流动力学变量、气体交换、乳酸酸中毒和凝血异常有有益作用。尸检时较高的胶体渗透压和较低的肺湿/干比提示内皮完整性得以保留。给予APC导致生存期延长。